Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thrombagglutination test (TAT) in hyper- and hypocoagulation].

K Atanasov

    Vutreshni Bolesti
    |January 1, 1975
    PubMed
    Summary

    The Breddin thrombagglutination test (TAT) effectively identifies hypercoagulation in atherosclerosis and myocardial infarction, and hypocoagulation in thrombopenia. A "zero stage" was introduced for hypocoagulation states.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.

    Oncogene·2013
    Same author

    [Reactive arthropathies in malignant hemoblastoses].

    Terapevticheskii arkhiv·1991
    Same author

    [Organization model for mass orthodontic prophylaxis in integrated pediatric institutions].

    Stomatologiia. Stomatology·1989
    Same author

    [Intravenous pulsed therapy with prednisolone hemisuccinate in severe forms of systemic lupus erythematosus].

    Vutreshni bolesti·1988
    Same author

    [Renal onset of multiple myeloma].

    Vutreshni bolesti·1988
    Same author

    [Case report on the diagnosis and therapy of hairy-cell leukemia].

    Vutreshni bolesti·1987

    Area of Science:

    • Cardiology
    • Hematology
    • Clinical Pathology

    Context:

    • Hypercoagulation and hypocoagulation states significantly impact cardiovascular health.
    • Conditions like atherosclerosis, myocardial infarction, and thrombopenia require accurate diagnostic tools.

    Purpose:

    • To evaluate the efficacy of the Breddin thrombagglutination test (TAT) in differentiating hypercoagulation and hypocoagulation states.
    • To establish the diagnostic value of TAT in patients with atherosclerosis, angina pectoris, myocardial infarction, and thrombopenia.

    Summary:

    • The Breddin thrombagglutination test (TAT) demonstrated high positivity rates in hypercoagulation states: 88% in atherosclerosis and 100% (Vth stage) in angina pectoris gravis and acute myocardial infarction.
    • In hypocoagulation states (thrombopenia), TAT was predominantly at the newly introduced "zero stage" (91% of patients), with only 9% showing Stage I.
    • The study introduces the "zero stage" to characterize severe hypocoagulation.

    Impact:

    • The Breddin thrombagglutination test provides a valuable diagnostic marker for assessing coagulation status in cardiovascular and hematological disorders.
    • Introduction of the "zero stage" refines the characterization of hypocoagulation, aiding in more precise patient management.

    Related Experiment Videos